BATS BZX Real-Time Price
| -0.26 / -2.27%|
The 4 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 23.50, with a high estimate of 33.00 and a low estimate of 13.00. The median estimate represents a +109.63% increase from the last price of 11.21.
The current consensus among 4 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.